PharmaNutra SpA (MIL:PHN) Margin of Safety % (DCF FCF Based): -317.82% (As of Jun. 26, 2026)


MIL:PHN PharmaNutra SpA MIL:PHN
85 GF Score
Price €87.20
GF Value €71.38
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PharmaNutra SpA Margin of Safety % (DCF FCF Based)?

PharmaNutra SpA MIL:PHN -1.91% 85 Margin of Safety % (DCF FCF Based) is -317.82% as of Jun. 26, 2026. GuruFocus rates MIL:PHN with a GF Score™ of 85/100 and a GF Value™ of €71.38 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-26), PharmaNutra SpA's Predictability Rank is 4.5-Stars. PharmaNutra SpA's intrinsic value calculated from the Discounted FCF model is €60.08 and current share price is €87.20. Consequently,

PharmaNutra SpA's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -317.82%.

MIL:PHN vs ZTS, UTHR, VTRS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaNutra SpA's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaNutra SpA Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaNutra SpA's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where PharmaNutra SpA's Margin of Safety % (DCF FCF Based) falls into.


MIL:PHN
85GF Score
PharmaNutra SpA MIL:PHN
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaNutra SpA Margin of Safety % (DCF FCF Based) Calculation

PharmaNutra SpA's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(20.87-87.20)/20.87
=-317.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

What does a Margin of Safety % (DCF FCF Based) of -317.82% mean?
PharmaNutra SpA (MIL:PHN) has a Margin of Safety % (DCF FCF Based) of -317.82% as of Jun. 26, 2026. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on PharmaNutra SpA.
Is PharmaNutra SpA's Margin of Safety % (DCF FCF Based) too high?
PharmaNutra SpA's current Margin of Safety % (DCF FCF Based) is -317.82%. Overall, PharmaNutra SpA has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PharmaNutra SpA's Margin of Safety % (DCF FCF Based) compare to ZTS and UTHR?
PharmaNutra SpA's Margin of Safety % (DCF FCF Based) of -317.82% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF FCF Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF FCF Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF FCF Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF FCF Based) mean?
A high Margin of Safety % (DCF FCF Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on PharmaNutra SpA. PharmaNutra SpA's current Margin of Safety % (DCF FCF Based) is -317.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaNutra SpA stock overvalued right now?
Based on GuruFocus' analysis, PharmaNutra SpA (MIL:PHN) is currently considered Modestly Overvalued. The stock's GF Value™ is €71.38, compared to a current price of €87.20 — trading 22.2% above its estimated fair value. The current Margin of Safety % (DCF FCF Based) is -317.82%. PharmaNutra SpA's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF FCF Based) calculated?
Margin of Safety % (DCF FCF Based) is calculated from a company's financial statements. For PharmaNutra SpA (MIL:PHN), the current Margin of Safety % (DCF FCF Based) is -317.82% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaNutra SpA (MIL:PHN) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be overvalued. The current stock price of €87.20 is trading 22.2% above its estimated GF Value™ of €71.38. GuruFocus considers PharmaNutra SpA to be Modestly Overvalued.

Key valuation signals for MIL:PHN:

  • Margin of Safety % (DCF FCF Based): -317.82%
  • GF Value™: €71.38 vs. price of €87.20 (22.2% above fair value)
  • GF Score™: 85/100 with 6 warning signs

No single metric tells the full story. See the MIL:PHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaNutra SpA Business Description

Other Exchanges PHNm:UK761:Germany
Address Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
85GF Score

Get the complete analysis for MIL:PHN

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.20
Price
€71.38
GF Value